Get the Stockscreener App
2.24
1.32%
-0.03
Tela Bio Inc stock is traded at $2.24, with a volume of 192.23K.
It is down -1.32% in the last 24 hours and down -13.85% over the past month.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.
See More
Previous Close:
$2.27
Open:
$2.28
24h Volume:
192.23K
Relative Volume:
1.21
Market Cap:
$88.23M
Revenue:
$63.15M
Net Income/Loss:
$-40.30M
P/E Ratio:
-1.3413
EPS:
-1.67
Net Cash Flow:
$-44.47M
1W Performance:
-7.82%
1M Performance:
-13.85%
6M Performance:
-15.47%
1Y Performance:
-59.64%
1-Day Range:
$2.18
$2.28
1-Week Range:
$2.18
$2.49
52-Week Range:
$2.18
$6.50
Tela Bio Inc Stock (TELA) Company Profile
Name
Tela Bio Inc
Sector
Industry
Phone
484-320-2930
Address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
2.24 | 88.23M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-31-22 | Initiated | Lake Street | Buy |
| Dec-03-19 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | JMP Securities | Mkt Outperform |
| Dec-03-19 | Initiated | Jefferies | Buy |
| Dec-03-19 | Initiated | Piper Jaffray | Overweight |
Tela Bio Inc Stock (TELA) Latest News
TELA Bio (TELA) to Release Earnings on Thursday - Defense World
TELA Bio stock plunges to 52-week low, touches $2.24 By Investing.com - Investing.com Australia
TELA Bio stock plunges to 52-week low, touches $2.24 - Investing.com India
Passage Bio Reports 2024 Financial Results and Advances in PBFT02 Program - MyChesCo
TELA Bio Stock Hits 52-Week Low at $2.26 Amid Market Challenges By Investing.com - Investing.com South Africa
TELA Bio Stock Hits 52-Week Low at $2.26 Amid Market Challenges - Investing.com
TELA Bio Grants Inducement Stock Units to New Employees - MSN
TELA Bio to Announce Fourth Quarter and Full-Year 2024 Financial Results - MSN
TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
TELA Bio, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025 - Nasdaq
When Will TELA Bio Release Q4 Earnings? Mark Your Calendar for March 20 - StockTitan
TELA Bio Announces Inducement Grants to Newly Hired Employees - MSN
TELA Bio Inc to Host Earnings Call - ACCESS Newswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Can TELA Bio's Latest Hiring Spree Signal a Growth Phase? New Equity Grants Tell the Story - StockTitan
Avantor CEO to Speak at TD Cowen’s 45th Annual Health Care Conference - MSN
TELA Bio, Inc. (NASDAQ:TELA): Is Breakeven Near? - Simply Wall St
Short Interest in TELA Bio, Inc. (NASDAQ:TELA) Increases By 17.8% - MarketBeat
TELA Bio (NASDAQ:TELA) Shares Down 1.4%Should You Sell? - MarketBeat
Annovis Bio Raises $21 Million in Public Offering to Advance Alzheimer’s Research - MyChesCo
Donegal Group to Announce Fourth-Quarter and Full-Year 2024 Financial Results - MyChesCo
Annovis Bio Announces Public Offering of Common Stock and Warrants - MyChesCo
US Cosmetic Surgery Market Size, Share, Trends, Forecast 2025-2034Custom Market Insights - BioSpace
TELA Bio Awards Equity Incentives to Seven New Strategic Hires - StockTitan
Jane Street Group LLC Sells 76,505 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio, Inc. (NASDAQ:TELA) Shares Sold by Geode Capital Management LLC - Defense World
Retail investors account for 41% of TELA Bio, Inc.'s (NASDAQ:TELA) ownership, while institutions account for 28% - Yahoo Finance
Aclaris Therapeutics Awards Stock Options to Attract Top Talent - MyChesCo
Aroa Biosurgery Introduces New Incentive Plans to Bolster Workforce Engagement - TipRanks
TELA Bio, Inc. (NASDAQ:TELA) Shares Sold by State Street Corp - Defense World
TELA Bio (NASDAQ:TELA) Stock Price Down 0.3% – Here’s Why - Defense World
TELA Bio (NASDAQ:TELA) Stock Price Down 0.3%Should You Sell? - MarketBeat
TELA Bio Announces Inducement Grants for New Employees - MSN
TELA Bio's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Canada
TELA Bio's SWOT analysis: stock poised for growth amid challenges - Investing.com
TELA Bio Awards Strategic Inducement Grants to Secure Key New Talent - StockTitan
The past five years for TELA Bio (NASDAQ:TELA) investors has not been profitable - Yahoo Finance
Earnings call: TELA Bio reports strong Q3 growth, eyes future gains - Investing.com Nigeria
Tela Bio Inc Stock (TELA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):